Prognostic Value of Inflammatory Indices in Papillary Gastric Carcinoma with Different Proportions of Papillary Components

  • 0Department of Gastroenterological Surgery, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, 150081, People's Republic of China.

|

|

Summary

This summary is machine-generated.

Peripheral inflammatory indices like neutrophil-to-lymphocyte ratio (NLR) and systemic immune-inflammatory index (SII) significantly impact prognosis in advantage papillary gastric carcinoma (APGC) and non-advantage papillary gastric carcinoma (NAPGC). These markers aid in predicting patient outcomes.

Area Of Science

  • Oncology
  • Gastroenterology
  • Inflammation Research

Background

  • Gastric cancer subtypes, including advantage papillary gastric carcinoma (APGC) and non-advantage papillary gastric carcinoma (NAPGC), exhibit distinct clinicopathological features.
  • Peripheral inflammatory indices are increasingly recognized for their potential role in cancer prognostication.

Purpose Of The Study

  • To evaluate the prognostic significance of peripheral inflammatory indices in patients with APGC and NAPGC.
  • To identify independent prognostic factors for each gastric cancer subtype.

Main Methods

  • Retrospective analysis of 270 patients undergoing radical surgery, stratified into APGC (≥50% papillary histology) and NAPGC (<50% papillary histology) cohorts.
  • Assessment of inflammatory indices, clinicopathological characteristics, and survival outcomes using ROC analysis, Kaplan-Meier, Log rank tests, and Cox regression.
  • Development and validation of a nomogram integrating prognostic factors for predictive performance evaluation.

Main Results

  • APGC patients presented with higher pT stage, elevated carcinoembryonic antigen (CEA), and poorer survival compared to NAPGC patients.
  • Neutrophil-to-lymphocyte ratio (NLR) and CEA were independent prognostic factors for APGC.
  • Systemic immune-inflammatory index (SII), age, and pN stage were independent prognostic factors for NAPGC.

Conclusions

  • Distinct clinicopathological characteristics, inflammatory profiles, and prognoses exist between APGC and NAPGC.
  • A nomogram incorporating NLR and SII demonstrates effective prognostic prediction for both APGC and NAPGC patients.

Related Concept Videos

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies 01:28

202

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.

Location of Pain:...

Gastritis-I: Introduction and Types 01:27

968

Gastritis, defined by the inflammation or irritation of the stomach lining or gastric mucosa, manifests in several distinct forms: acute, chronic, reactive, and a specific subtype known as autoimmune metaplastic atrophic gastritis.
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...

Gastritis III: Clinical Manifestations and Management 01:23

484

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...